Skip to main content

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

The Original Article was published on 22 July 2020

Correction: BMC Cancer 20, 681 (2020)

https://doi.org/10.1186/s12885-020-07167-8

Following publication of the original article [1], the authors have identified an error, specifically the overlapping of the two images in Fig. 2a (24 h, DFX 10 μm and DFX 100 μM), which was pointed out to us by the editorial team. The corrected Fig. 2 is given in this correction article.

Fig. 2
figure 1

Effect of DFX on migratory ability of pancreatic cancer cells. Pancreatic cancer cell lines (BxPC-3, Panc-1, HPAFII) were treated with DFX (0, 10, 50, 100 μM) and incubated for 24 h. a-c Migrated cells were visualized via phase-contrast microscopy. d-f % wound closure was measured and the ratio to wound width at the start of the incubation was used as an index of cell migration, compared to control group (n = 3 each). Data are presented as mean ± SD. *P < 0.01 vs control

Reference

  1. Amano S, Kaino S, Shinoda S, et al. Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. BMC Cancer. 2020;20:681. https://doi.org/10.1186/s12885-020-07167-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Taro Takami.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amano, S., Kaino, S., Shinoda, S. et al. Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. BMC Cancer 23, 582 (2023). https://doi.org/10.1186/s12885-023-11091-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12885-023-11091-y